Risk/stage | Recurrence-free survival 5 years (%) | Time interval to transplant | Additional considerations |
Low risk
| 91 | 1 year | Low-risk features:
High-risk features:
Tumor deposits considered as N+ disease. Consider chemotherapy prior to transplantation for high-risk stage II disease. Patients with stage III disease should complete chemotherapy. |
Low intermediate risk
| 72 | 2 years, consider longer if high-risk features present | |
High intermediate risk
| 3 years, 5 years if high-risk features present | ||
High risk
| 13 | 5 years NED | SOT not recommended prior to 5 years; refer to special consideration regarding resectable CRC metastasis |
Do you want to add Medilib to your home screen?